Oramed Pharmaceuticals (ORMP) Exchange Rate Effect (2011 - 2026)
Oramed Pharmaceuticals' (ORMP) quarterly Exchange Rate Effect came in at $22000.0 in Q1 2026, up 2300.0% YoY from $916.67 in Q1 2025, and up 130.14% on a QoQ basis from -$73000.0 in Q4 2025.
Oramed Pharmaceuticals (ORMP) Exchange Rate Effect (2011 - 2026) Analysis & Trends
Oramed Pharmaceuticals (ORMP) has 16 years of Exchange Rate Effect data on file, last reported at $22000.0 in Q1 2026.
- Quarterly Exchange Rate Effect rose 2300.0% year-over-year to $22000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7000.0 (down 75.0% YoY) and the FY2025 annual result came in at -$30000.0, down 650.0% from the prior year.
- Exchange Rate Effect advanced to $22000.0 in Q1 2026, from -$73000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $40000.0 in Q2 2025 to a low of -$105000.0 in Q4 2022.
- A 5-year average of -$9562.5 and a median of $1000.0 in 2022 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2025 — Exchange Rate Effect tumbled 3550.0% — and 2026, when it soared 2300.0%.
- Tracing ORMP's Exchange Rate Effect over 5 years: stood at -$105000.0 in 2022, then surged by 107.62% to $8000.0 in 2023, then tumbled by 125.0% to -$2000.0 in 2024, then plunged by 3550.0% to -$73000.0 in 2025, then jumped by 130.14% to $22000.0 in 2026.
- The last three Exchange Rate Effect figures came in at $22000.0 (Q1 2026), -$73000.0 (Q4 2025), and $4000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.33 Bn | 78.34 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.13 Bn | 59.95 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.47 Bn | 55.33 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.04 Bn | 27.73 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.48 Bn | 10.09 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.23 Bn | 26.39 Bn | - | - |
| 10 | Oramed Pharmaceuticals | 197.40 Mn | 197.40 Mn | - | -118,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -118,000.00 |
| Jun 30, 2026 | -118,000.00 |
| Mar 31, 2026 | 22,000.00 |
| Mar 31, 2026 | 22,000.00 |
| Dec 31, 2025 | -73,000.00 |
| Dec 31, 2025 | -73,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | -4,000.00 |
| Jun 30, 2024 | -4,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Mar 31, 2024 | -1,000.00 |